SELLAS Life Sciences (SLS) Interest Expenses (2011 - 2026)

SELLAS Life Sciences (SLS) has 16 years of Interest Expenses data on file, last reported at $5.8 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 2800.5% year-over-year to $5.8 million in Q1 2026; TTM through Mar 2026 was $5.8 million, a 1060.2% increase from a year earlier, with the FY2025 full-year figure at $22.8 million, up 9.45% from the prior year.
• Interest Expenses for Q1 2026 stood at $5.8 million, up from $100000.0 in the prior quarter.
• Over the last five years, Interest Expenses for SLS reached as high as $5.8 million in Q1 2026 and fell as low as $100000.0 in Q1 2022.
• Historically, Interest Expenses has averaged $568058.8 across 5 years, with a median of $100000.0 in 2022.
• Across the five-year window, Interest Expenses slumped 50.0% in 2023 and surged 2800.5% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $200000.0 in 2022, then slumped by 50.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then soared by 5701.0% to $5.8 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $5.8 million in Q1 2026, $100000.0 in Q4 2025, and $200000.0 in Q3 2025.